Cellebrite DI Income Statement (2020-2025) | CLBT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	53.28M	59.17M	65.89M	67.91M	62.38M	62.57M	71.67M	74.02M	71.23M	76.68M	84.18M	93.01M	89.58M	95.71M	106.86M	109.05M	107.55M	113.28M	126.03M	128.82M
Cost of Revenue (Quarter)	8.20M	10.07M	11.95M	12.34M	10.98M	13.10M	14.53M	12.13M	12.41M	13.03M	12.88M	14.92M	13.26M	16.26M	15.44M	17.62M	17.49M	17.68M	20.31M	19.69M
Gross Profit (Quarter)	45.08M	49.10M	53.93M	55.57M	51.40M	49.48M	57.14M	61.89M	58.83M	63.65M	71.30M	78.10M	76.32M	79.45M	91.41M	91.42M	90.06M	95.60M	105.72M	109.13M
Operating items
Amortization - Intangibles (Quarter)				0.61M	0.66M	0.66M	0.66M	0.83M	0.80M	0.84M	0.84M	0.87M	0.93M		0.79M	0.86M	0.93M		0.93M	2.11M
Depreciation & Amortization - Total (Quarter)							1.64M	-4.68M			1.54M	1.74M
Research & Development (Quarter)	14.89M	15.39M	16.43M	18.83M	19.58M	19.68M	21.64M	19.73M	21.13M	21.05M	20.45M	21.75M	23.20M	23.69M	25.93M	25.60M	27.28M	28.61M	28.12M	29.86M
Selling, General & Administrative (Quarter)	9.29M	6.98M	20.48M	11.19M	10.51M	10.51M	11.02M	8.81M	9.96M	11.23M	10.50M	11.75M	11.81M	10.95M	13.56M	14.57M	11.75M	13.89M	19.80M	19.90M
Restructuring Costs (Quarter)				1.18M	1.06M	0.39M	0.38M	0.13M	0.26M	-0.32M	0.05M	0.05M	0.01M		0.21M				0.16M	1.59M
Other Operating Expenses (Quarter)	16.52M	18.51M	20.12M	20.06M	22.20M	24.50M	23.55M	28.21M	27.34M	27.07M	25.28M	27.80M	32.05M	32.32M	32.27M	35.52M	38.77M	38.69M	38.64M	36.97M
Operating Expenses (Quarter)	40.70M	40.88M	57.02M	51.27M	53.35M	55.07M	58.23M	52.21M	58.69M	59.03M	57.82M	63.10M	67.07M	66.97M	71.97M	75.70M	77.79M	81.18M	86.72M	88.33M
Operating Income (Quarter)	4.39M	8.22M	-3.09M	4.31M	-1.95M	-5.60M	-1.08M	-7.59M	0.14M	4.62M	13.48M	15.00M	9.25M	12.49M	19.45M	15.73M	12.27M	14.42M	18.99M	20.80M
EBIT (Quarter)	4.39M	8.22M	-3.09M	4.31M	-1.95M	-5.60M	-1.08M	-7.59M	0.14M	4.62M	13.48M	15.00M	9.25M	12.49M	19.45M	15.73M	12.27M	14.42M	18.99M	20.80M
Non-operating items
Non Operating Investment Income (Quarter)					-0.05M	-0.24M	-0.26M	0.04M	0.18M	-0.05M	0.09M	0.29M	-0.22M	-0.10M	0.84M	-0.41M	0.06M	2.79M	0.20M	0.02M
Interest & Investment Income (Quarter)				1.66M	2.86M	3.60M	3.46M	3.79M	4.46M	4.60M	4.88M	5.06M	5.70M
Other Non Operating Income (Quarter)	0.46M	-0.41M	-0.01M	0.95M	0.40M	0.41M	-0.27M	-0.13M	-38.77M	-36.05M	-6.63M	-0.95M	1.18M	-34.50M	-1.78M	1.82M	-0.48M	-1.23M	0.29M	0.12M
Non Operating Income (Quarter)	0.37M	0.50M	17.81M	49.81M	56.40M	38.47M	-25.42M	240.00M			6.63M	-27.34M	-78.58M	-34.50M	-223.98M	4.17M	7.06M	6.37M	5.30M	5.47M
Net income details
EBT (Quarter)	4.75M	8.72M	14.72M	54.12M	54.45M	32.87M	24.34M	9.10M	-38.64M	-31.43M	6.85M	-12.35M	-69.33M	-22.02M	-204.54M	19.90M	19.33M	20.79M	24.29M	26.27M
Tax Provisions (Quarter)	1.16M	0.92M	6.58M	2.24M	-0.98M	-0.33M	-0.76M	2.02M	1.97M	0.92M	0.35M	2.30M	2.04M	1.80M	2.56M	0.63M	1.93M	1.31M	4.10M	5.01M
Profit After Tax (Quarter)	3.59M	7.80M	8.14M	51.87M	55.44M	33.20M	25.09M	7.08M	40.60M	-32.35M	6.50M	-14.65M	71.37M	23.81M	-207.09M	19.27M	17.40M	19.48M	20.19M	21.26M
Equity Income (Quarter)			-0.17M	0.49M
Income from Non-Controlling Interests (Quarter)	2.67M	7.51M	7.95M	1.45M	54.64M	31.61M	25.33M	1.10M			7.38M	-13.99M	-70.93M	71.13M	-207.93M	20.94M	16.20M	-15.65M	20.01M	21.02M
Income from Continuing Operations (Quarter)	3.59M	7.80M	8.14M	51.87M	55.44M	33.20M	25.09M	7.08M	-40.60M	-32.35M	6.50M	-14.65M	-71.37M	-23.81M	-207.09M	19.27M	17.40M	19.48M	20.19M	21.26M
Consolidated Net Income (Quarter)	3.59M	7.80M	8.14M	51.87M	55.44M	33.20M	25.09M	7.08M	-40.60M	-32.35M	6.50M	-14.65M	-71.37M	-23.81M	-207.09M	19.27M	17.40M	19.48M	20.19M	21.26M
Income towards Parent Company (Quarter)	3.59M	7.80M	8.14M	51.87M	55.44M	33.20M	25.09M	7.08M	-40.60M	-32.35M	6.50M	-14.65M	-71.37M	-23.81M	-207.09M	19.27M	17.40M	19.48M	20.19M	21.26M
Net Income towards Common Stockholders (Quarter)	3.59M	7.80M	8.14M	51.87M	55.44M	33.20M	25.09M	7.08M	-40.60M	-32.35M	6.50M	-14.65M	-71.37M	-23.81M	-207.09M	19.27M	17.40M	19.48M	20.19M	21.26M
Additional items
EPS (Basic) (Quarter)	0.03	0.06	0.06	0.36	0.31	0.18	0.14	0.04	-0.22	-0.17	0.03	-0.08	-0.36	-0.12	-0.99	0.09	0.07	0.08	0.08	0.09
EPS (Diluted) (Quarter)	0.03	0.06	0.05	0.32	0.28	0.17	0.13	0.04	-0.20	-0.17	0.03	-0.08	-0.34	-0.11	-0.91	0.09	0.07	0.08	0.08	0.09
Shares Outstanding (Quarter)	130.08M	125.40M	144.85M	144.00M	180.55M	181.91M	183.28M	182.69M	186.34M	188.13M	191.57M	190.15M	196.82M	198.95M	208.71M	209.47M	237.25M	240.36M	243.51M	241.63M
Shares Outstanding (Diluted) (Quarter)	130.08M	125.40M	163.35M	161.54M	196.14M	194.36M	194.97M	195.39M	198.18M	187.24M	204.39M	190.15M	211.26M	211.34M	226.88M	209.47M	252.46M	252.71M	256.16M	249.90M
EBITDA (Quarter)	4.39M	8.22M	-3.09M	4.31M	-1.95M	-5.60M	5.05M	-9.77M	0.14M	4.62M	20.79M	22.76M	9.25M	12.49M	19.45M	15.73M	12.27M	14.42M	18.99M	20.80M
Interest Expenses (Quarter)			0.74M	-4.94M				0.77M				0.75M				1.23M				9.21M
Tax Rate (Quarter)	24.47%	10.57%	44.71%	4.15%	-1.81%	-1.00%	-3.10%	22.24%	-5.09%	-2.93%	5.10%	-18.65%	-2.95%	-8.16%	-1.25%	3.16%	9.98%	6.32%	16.88%	19.07%

Research Tools

Developers

Cellebrite DI Income Statement (2020-2025) | CLBT

Research Tools

Developers

Cellebrite DI Income Statement (2020-2025) | CLBT

Create an account

Sign In

Reset Password